Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?
Juliana Maria Dantas Mendonça Borges,1,2,* Fernanda Oliveira de Carvalho,1,* Isla Alcântara Gomes,3,* Mario Borges Rosa,4,* Antonio Carlos Sobral Sousa1,* 1Nucleus of Post-Graduation in Health Sciences, Federal University of Sergipe, São Cristóvã...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-10-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/antiplatelet-agents-in-perioperative-noncardiac-surgeries-to-maintain--peer-reviewed-article-TCRM |
| _version_ | 1818575039754141696 |
|---|---|
| author | Borges JMDM Oliveira de Carvalho F Gomes IA Borges Rosa M Sousa ACS |
| author_facet | Borges JMDM Oliveira de Carvalho F Gomes IA Borges Rosa M Sousa ACS |
| author_sort | Borges JMDM |
| collection | DOAJ |
| description | Juliana Maria Dantas Mendonça Borges,1,2,* Fernanda Oliveira de Carvalho,1,* Isla Alcântara Gomes,3,* Mario Borges Rosa,4,* Antonio Carlos Sobral Sousa1,* 1Nucleus of Post-Graduation in Health Sciences, Federal University of Sergipe, São Cristóvão, Brazil; 2Nucleus of Pharmacy, Tiradentes University, Aracaju, Brazil; 3Nucleus of Post-Graduation in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Brazil; 4Institute for Safe Practice in Drug Use, Belo Horizonte, Brazil *These authors contributed equally to this work Background: When prescribing antiplatelet agents, physicians face the challenge of protecting patients from thromboembolic events without inducing bleeding damage. However, especially in the perioperative period, the use of these medications requires a carefully balanced assessment of their risks and benefits.Objective: To conduct a systematic review to check whether the antiplatelet agent is to be maintained or suspended in the perioperative period of noncardiac surgeries.Search strategy: A comprehensive literature search using Science Direct, Scopus, MEDLINE-PubMed, and Web of Science was undertaken.Selection criteria: Clinical trials of noncardiac surgeries with patients taking regular antiplatelet therapy, published between 2013 and 2018.Results: A total of 1,302 studies were initially identified, with only four meeting the inclusion criteria. The selected studies were conducted in different countries such as, including India (2), Serbia (1), and the USA (1). The age group was similar in all studies, from 61 to 75 years. The most frequent surgery was related to tooth extraction and transurethral resection of bladder cancer. There was a group of patients who used single antiplatelet agents and groups who used single therapy and double therapy. Acetylsalicylic acid was the common drug in all studies.Conclusion: It was concluded that the clinical trials were classified as good quality and that it was not necessary to suspend antiplatelet therapy prior to surgical procedures such as dental extraction and transurethral resection of bladder cancer. It should be noted that it is necessary to jointly evaluate the type of antiplatelet agent, the thrombotic risk of the patient, and the hemorrhagic risk of the surgical procedure. Keywords: platelet aggregation inhibitors, antiplatelet agent, surgery, systematic review |
| first_indexed | 2024-12-15T00:34:56Z |
| format | Article |
| id | doaj.art-476174de9d80440da8c90f387631c6d9 |
| institution | Directory Open Access Journal |
| issn | 1178-203X |
| language | English |
| last_indexed | 2024-12-15T00:34:56Z |
| publishDate | 2018-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Therapeutics and Clinical Risk Management |
| spelling | doaj.art-476174de9d80440da8c90f387631c6d92022-12-21T22:41:50ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2018-10-01Volume 141887189541179Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?Borges JMDMOliveira de Carvalho FGomes IABorges Rosa MSousa ACSJuliana Maria Dantas Mendonça Borges,1,2,* Fernanda Oliveira de Carvalho,1,* Isla Alcântara Gomes,3,* Mario Borges Rosa,4,* Antonio Carlos Sobral Sousa1,* 1Nucleus of Post-Graduation in Health Sciences, Federal University of Sergipe, São Cristóvão, Brazil; 2Nucleus of Pharmacy, Tiradentes University, Aracaju, Brazil; 3Nucleus of Post-Graduation in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Brazil; 4Institute for Safe Practice in Drug Use, Belo Horizonte, Brazil *These authors contributed equally to this work Background: When prescribing antiplatelet agents, physicians face the challenge of protecting patients from thromboembolic events without inducing bleeding damage. However, especially in the perioperative period, the use of these medications requires a carefully balanced assessment of their risks and benefits.Objective: To conduct a systematic review to check whether the antiplatelet agent is to be maintained or suspended in the perioperative period of noncardiac surgeries.Search strategy: A comprehensive literature search using Science Direct, Scopus, MEDLINE-PubMed, and Web of Science was undertaken.Selection criteria: Clinical trials of noncardiac surgeries with patients taking regular antiplatelet therapy, published between 2013 and 2018.Results: A total of 1,302 studies were initially identified, with only four meeting the inclusion criteria. The selected studies were conducted in different countries such as, including India (2), Serbia (1), and the USA (1). The age group was similar in all studies, from 61 to 75 years. The most frequent surgery was related to tooth extraction and transurethral resection of bladder cancer. There was a group of patients who used single antiplatelet agents and groups who used single therapy and double therapy. Acetylsalicylic acid was the common drug in all studies.Conclusion: It was concluded that the clinical trials were classified as good quality and that it was not necessary to suspend antiplatelet therapy prior to surgical procedures such as dental extraction and transurethral resection of bladder cancer. It should be noted that it is necessary to jointly evaluate the type of antiplatelet agent, the thrombotic risk of the patient, and the hemorrhagic risk of the surgical procedure. Keywords: platelet aggregation inhibitors, antiplatelet agent, surgery, systematic reviewhttps://www.dovepress.com/antiplatelet-agents-in-perioperative-noncardiac-surgeries-to-maintain--peer-reviewed-article-TCRMplatelet aggregation inhibitorsantiplatelet agentsurgerysystematic review |
| spellingShingle | Borges JMDM Oliveira de Carvalho F Gomes IA Borges Rosa M Sousa ACS Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend? Therapeutics and Clinical Risk Management platelet aggregation inhibitors antiplatelet agent surgery systematic review |
| title | Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend? |
| title_full | Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend? |
| title_fullStr | Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend? |
| title_full_unstemmed | Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend? |
| title_short | Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend? |
| title_sort | antiplatelet agents in perioperative noncardiac surgeries to maintain or to suspend |
| topic | platelet aggregation inhibitors antiplatelet agent surgery systematic review |
| url | https://www.dovepress.com/antiplatelet-agents-in-perioperative-noncardiac-surgeries-to-maintain--peer-reviewed-article-TCRM |
| work_keys_str_mv | AT borgesjmdm antiplateletagentsinperioperativenoncardiacsurgeriestomaintainortosuspend AT oliveiradecarvalhof antiplateletagentsinperioperativenoncardiacsurgeriestomaintainortosuspend AT gomesia antiplateletagentsinperioperativenoncardiacsurgeriestomaintainortosuspend AT borgesrosam antiplateletagentsinperioperativenoncardiacsurgeriestomaintainortosuspend AT sousaacs antiplateletagentsinperioperativenoncardiacsurgeriestomaintainortosuspend |